Full Text View
Tabular View
No Study Results Posted
Related Studies
Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.
This study has been completed.
Study NCT00367653   Information provided by Pfizer
First Received: August 21, 2006   Last Updated: September 15, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malaria
Additional conditions recognized in this trial
Malaria, Falciparum
More general conditions related to this trial
Coccidiosis
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
Azithromycin plus Chloroquine
Mefloquine
Additional drug interventions recognized in this trial
Azithromycin
Chloroquine
Chloroquine diphosphate
More general drug interventions related to this trial
Amebicides
Analgesics
Analgesics, Non-Narcotic
Anthelmintics
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antimalarials
Antinematodal Agents
Antiparasitic Agents
Antiprotozoal Agents
Antirheumatic Agents
Central Nervous System Agents
Filaricides
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services